228 related articles for article (PubMed ID: 27764126)
21. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma.
Lake SL; Coupland SE; Taktak AF; Damato BE
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4884-91. PubMed ID: 20445121
[TBL] [Abstract][Full Text] [Related]
22. Lower Levels of Adiponectin and Its Receptor Adipor1 in the Uveal Melanomas With Monosomy-3.
Tura A; Thieme C; Brosig A; Merz H; Ranjbar M; Vardanyan S; Zuo H; Maassen T; Kakkassery V; Grisanti S
Invest Ophthalmol Vis Sci; 2020 May; 61(5):12. PubMed ID: 32396633
[TBL] [Abstract][Full Text] [Related]
23. Identification of prognostic genes in uveal melanoma microenvironment.
Luo H; Ma C
PLoS One; 2020; 15(11):e0242263. PubMed ID: 33196683
[TBL] [Abstract][Full Text] [Related]
24. Association of HLA class I and class II antigen expression and mortality in uveal melanoma.
Ericsson C; Seregard S; Bartolazzi A; Levitskaya E; Ferrone S; Kiessling R; Larsson O
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2153-6. PubMed ID: 11527924
[TBL] [Abstract][Full Text] [Related]
25. Expression of classic and nonclassic HLA class I antigens in uveal melanoma.
Anastassiou G; Rebmann V; Wagner S; Bornfeld N; Grosse-Wilde H
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2016-9. PubMed ID: 12714638
[TBL] [Abstract][Full Text] [Related]
26. Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment.
Gezgin G; Dogrusöz M; van Essen TH; Kroes WGM; Luyten GPM; van der Velden PA; Walter V; Verdijk RM; van Hall T; van der Burg SH; Jager MJ
Cancer Immunol Immunother; 2017 Jul; 66(7):903-912. PubMed ID: 28391358
[TBL] [Abstract][Full Text] [Related]
27. Transporter associated protein expression in uveal melanoma.
Krishnakumar S; Lakshmi SA; Abhyankar D; Biswas J
Br J Ophthalmol; 2004 Jul; 88(7):925-8. PubMed ID: 15205239
[TBL] [Abstract][Full Text] [Related]
28. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
[TBL] [Abstract][Full Text] [Related]
29. Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.
van Gils W; Kilic E; Brüggenwirth HT; Vaarwater J; Verbiest MM; Beverloo B; van Til-Berg ME; Paridaens D; Luyten GP; de Klein A
Melanoma Res; 2008 Feb; 18(1):10-5. PubMed ID: 18227702
[TBL] [Abstract][Full Text] [Related]
30. Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.
Ibrahim EC; Aractingi S; Allory Y; Borrini F; Dupuy A; Duvillard P; Carosella ED; Avril MF; Paul P
Int J Cancer; 2004 Jan; 108(2):243-50. PubMed ID: 14639610
[TBL] [Abstract][Full Text] [Related]
31. Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3.
Nareyeck G; Zeschnigk M; Prescher G; Lohmann DR; Anastassiou G
Exp Eye Res; 2006 Oct; 83(4):858-64. PubMed ID: 16750193
[TBL] [Abstract][Full Text] [Related]
32. HLA class II antigen expression in uveal melanoma: correlation with clinicopathological features.
Krishnakumar S; Abhyankar D; Lakshmi SA; Shanmugam MP; Pushparaj V; Biswas J
Exp Eye Res; 2003 Aug; 77(2):175-80. PubMed ID: 12873447
[TBL] [Abstract][Full Text] [Related]
33. ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion.
Gangemi R; Amaro A; Gino A; Barisione G; Fabbi M; Pfeffer U; Brizzolara A; Queirolo P; Salvi S; Boccardo S; Gualco M; Spagnolo F; Jager MJ; Mosci C; Rossello A; Ferrini S
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1138-48. PubMed ID: 25124714
[TBL] [Abstract][Full Text] [Related]
34. Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
Triozzi PL; Elson P; Aldrich W; Achberger S; Tubbs R; Biscotti CV; Singh AD
Melanoma Res; 2013 Feb; 23(1):1-7. PubMed ID: 23196330
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
[TBL] [Abstract][Full Text] [Related]
36. Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases.
Trolet J; Hupé P; Huon I; Lebigot I; Decraene C; Delattre O; Sastre-Garau X; Saule S; Thiéry JP; Plancher C; Asselain B; Desjardins L; Mariani P; Piperno-Neumann S; Barillot E; Couturier J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2572-80. PubMed ID: 19151381
[TBL] [Abstract][Full Text] [Related]
37. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.
Versluis M; de Lange MJ; van Pelt SI; Ruivenkamp CA; Kroes WG; Cao J; Jager MJ; Luyten GP; van der Velden PA
PLoS One; 2015; 10(3):e0116371. PubMed ID: 25764247
[TBL] [Abstract][Full Text] [Related]
38. Effects of interferon alfa and gamma on human uveal melanoma cells in vitro.
de Waard-Siebinga I; Creyghton WM; Kool J; Jager MJ
Br J Ophthalmol; 1995 Sep; 79(9):847-55. PubMed ID: 7488605
[TBL] [Abstract][Full Text] [Related]
39. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
[TBL] [Abstract][Full Text] [Related]
40. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
Zeuthen J; Birck A; Straten PT
Arch Immunol Ther Exp (Warsz); 1995; 43(2):123-33. PubMed ID: 8744727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]